Eligible patients had COPD, were ages 40 or older, and were new initiators of these inhalers from 2021 to 2023. They were ...

Researchers gathered real-world data on biologic therapy to determine the feasibility of targeting clinical remission when ...

Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic ...

COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of life for patients. These devices range from inhalers to ...

End-stage COPD is marked by severe shortness of breath, even when at rest. At this stage, medications typically don’t work as well as they may have in the past. Everyday tasks will leave you ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Factors that can increase the risk of COPD include exposure to tobacco smoke, including secondhand smoke; asthma ... Treatment for COPD can include medications, such as inhalers; oxygen; pulmonary ...

.In December 2024:- AstraZeneca- A Phase II, Randomized, Double-blind, Single-dose, Placebo-controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study to Compare the Bronchodilatory Effect ...

There are many possible short-term and long-term complications of asthma, especially if it’s left untreated. The breathing problems it causes can affect your quality of life by affecting your sleep ...

A RECENT study examining real-world COPD treatment outcomes has highlighted safety concerns regarding single-inhaler triple therapy compared to the long-acting beta2-agonist (LABA) and inhaled ...